Gmo Emerging Financials

GMCDX Fund  USD 20.52  0.09  0.44%   
Financial data analysis helps to validate if markets are presently mispricing Gmo Emerging. We were able to break down eleven available reported financial drivers for Gmo Emerging Ntry, which can be compared to its competitors. The fund experiences a normal downward trend and little activity. Check odds of Gmo Emerging to be traded at $20.31 in 90 days.
  
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.

Gmo Emerging Fund Summary

Gmo Emerging competes with Gmo Emerging, Tcw Emerging, Jpmorgan Emerging, Gmo Emerging, and Sit Emerging. The fund invests primarily in debt of emerging country sovereign and quasi-sovereign issuers. Under normal circumstances, it invests directly and indirectly at least 80 percent of its assets in debt investments tied economically to emerging countries. In seeking to achieve the funds investment objective, the fund typically invests a portion of the funds assets in over-the-counter and exchange-traded derivatives, including options, swap contracts, forward currency contracts and reverse repurchase agreements.
Specialization
Emerging Markets Bond, Emerging Markets Bond
InstrumentUSA Mutual Fund View All
ExchangeNMFQS Exchange
ISINUS3620072708
Business AddressGMO Trust
Mutual Fund FamilyGMO
Mutual Fund CategoryEmerging Markets Bond
BenchmarkDow Jones Industrial
Phone617 346 7646
CurrencyUSD - US Dollar

Gmo Emerging Key Financial Ratios

Gmo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Gmo Emerging's current stock value. Our valuation model uses many indicators to compare Gmo Emerging value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gmo Emerging competition to find correlations between indicators driving Gmo Emerging's intrinsic value. More Info.
Gmo Emerging Ntry is one of the top funds in annual yield among similar funds. It is rated # 2 fund in year to date return among similar funds creating about  18.52  of Year To Date Return per Annual Yield. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gmo Emerging's earnings, one of the primary drivers of an investment's value.

Gmo Emerging Ntry Systematic Risk

Gmo Emerging's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Gmo Emerging volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Gmo Emerging Ntry correlated with the market. If Beta is less than 0 Gmo Emerging generally moves in the opposite direction as compared to the market. If Gmo Emerging Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Gmo Emerging Ntry is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Gmo Emerging is generally in the same direction as the market. If Beta > 1 Gmo Emerging moves generally in the same direction as, but more than the movement of the benchmark.
Gmo Emerging Ntry is rated # 3 fund in net asset among similar funds. Total Asset Under Management (AUM) of Emerging Markets Bond category is currently estimated at about 17.18 Billion. Gmo Emerging totals roughly 3.87 Billion in net asset claiming about 23% of all funds under Emerging Markets Bond category.

Gmo Emerging March 22, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Gmo Emerging help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Gmo Emerging Ntry. We use our internally-developed statistical techniques to arrive at the intrinsic value of Gmo Emerging Ntry based on widely used predictive technical indicators. In general, we focus on analyzing Gmo Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Gmo Emerging's daily price indicators and compare them against related drivers.

Other Information on Investing in Gmo Mutual Fund

Gmo Emerging financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Emerging security.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets